Astrana Health Inc. - Common Stock (ASTH)

39.67
+2.94 (8.00%)
NASDAQ · Last Trade: Nov 4th, 6:03 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Astrana Health (ASTH) reports Q3: everything you need to know ahead of earnings
Healthcare services company Astrana Health will be reporting results this Thursday afternoon. Here’s what investors should know. Astrana Health missed analys...
Via StockStory · November 3, 2026
2 of Wall Street’s Favorite Stocks to Target This Week and 1 We Ignore
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via StockStory · October 16, 2026
Astrana Health (ASTH): Buy, Sell, or Hold Post Q2 Earnings?
Astrana Health’s 35.1% return over the past six months has outpaced the S&P 500 by 19.8%, and its stock price has climbed to $37.03 per share. This run-up mi...
Via StockStory · October 8, 2026
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) ...
Via StockStory · September 29, 2026
Astrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beatchartmill.com
Via Chartmill · August 6, 2026
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentumchartmill.com
Via Chartmill · July 3, 2026
Why Astrana Health (ASTH) Shares Are Trading Lower Today
What Happened? Shares of healthcare services company Astrana Health fell 5.5% in the afternoon session after the company disclosed a "material" cybersecurity...
Via StockStory · September 23, 2026
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved Care Act, legislation aimed at re...
Via StockStory · September 15, 2026
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · September 15, 2026
2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Via StockStory · August 14, 2026
Astrana Health (ASTH) Q2 2026 Earnings Call Transcriptfool.com
Revenue jumped 49% to $972.5 million as adjusted EPS hit record $0.80.
Via The Motley Fool · August 13, 2026
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call
Astrana Health’s second quarter was met with a positive market response, as management highlighted several drivers behind the results. The company saw contin...
Via StockStory · August 13, 2026
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next ...
Via StockStory · August 7, 2026
Astrana Health Q2 Earnings Call Highlightsmarketbeat.com
Astrana Health (NASDAQ:ASTH) reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrang
Via MarketBeat · August 6, 2026
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1%
Healthcare services company Astrana Health fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million....
Via StockStory · August 6, 2026
Astrana Health (ASTH) Q2 Earnings: What To Expect
Healthcare services company Astrana Health will be reporting results this Thursday after market hours. Here’s what to look for. Astrana Health beat analysts’...
Via StockStory · August 4, 2026
2 Reasons to Like ASTH and 1 to Stay Skeptical
The past six months have been a windfall for Astrana Health’s shareholders. The company’s stock price has jumped 79%, hitting $49.01 per share. This was part...
Via StockStory · July 15, 2026
1 Profitable Stock to Target This Week and 2 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · July 10, 2026
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via StockStory · June 30, 2026
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via StockStory · June 15, 2026
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
Via StockStory · June 5, 2026
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via StockStory · May 25, 2026
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via StockStory · May 21, 2026
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · May 19, 2026
2 Mooning Stocks Worth Investigating and 1 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...
Via StockStory · May 15, 2026